TARS – tarsus pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison's Top 2 Picks [Seeking Alpha]
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $36.00 to $41.00. They now have a "neutral" rating on the stock.
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) had its price target raised by analysts at Oppenheimer Holdings Inc. from $63.00 to $65.00. They now have an "outperform" rating on the stock.
Tarsus Pharmaceuticals Inc (TARS) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ... [Yahoo! Finance]
Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
Form 8-K Tarsus Pharmaceuticals, For: Dec 16
Form 4 Tarsus Pharmaceuticals, For: Nov 13 Filed by: Goodrich Katherine
Form 3 Tarsus Pharmaceuticals, For: Nov 13 Filed by: Goodrich Katherine
Form SC 13G Tarsus Pharmaceuticals, Filed by: PRUDENTIAL FINANCIAL INC
Form SC 13G/A Tarsus Pharmaceuticals, Filed by: Paradigm Biocapital Advisors LP
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.